Correlation Between Xbrane Biopharma and Idogen AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xbrane Biopharma and Idogen AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xbrane Biopharma and Idogen AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xbrane Biopharma AB and Idogen AB, you can compare the effects of market volatilities on Xbrane Biopharma and Idogen AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xbrane Biopharma with a short position of Idogen AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xbrane Biopharma and Idogen AB.

Diversification Opportunities for Xbrane Biopharma and Idogen AB

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Xbrane and Idogen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Xbrane Biopharma AB and Idogen AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Idogen AB and Xbrane Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xbrane Biopharma AB are associated (or correlated) with Idogen AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Idogen AB has no effect on the direction of Xbrane Biopharma i.e., Xbrane Biopharma and Idogen AB go up and down completely randomly.

Pair Corralation between Xbrane Biopharma and Idogen AB

Assuming the 90 days trading horizon Xbrane Biopharma AB is expected to under-perform the Idogen AB. But the stock apears to be less risky and, when comparing its historical volatility, Xbrane Biopharma AB is 2.32 times less risky than Idogen AB. The stock trades about -0.02 of its potential returns per unit of risk. The Idogen AB is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  17.00  in Idogen AB on August 30, 2024 and sell it today you would lose (5.00) from holding Idogen AB or give up 29.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Xbrane Biopharma AB  vs.  Idogen AB

 Performance 
       Timeline  
Xbrane Biopharma 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Xbrane Biopharma AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Xbrane Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Idogen AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Idogen AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Idogen AB is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Xbrane Biopharma and Idogen AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xbrane Biopharma and Idogen AB

The main advantage of trading using opposite Xbrane Biopharma and Idogen AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xbrane Biopharma position performs unexpectedly, Idogen AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Idogen AB will offset losses from the drop in Idogen AB's long position.
The idea behind Xbrane Biopharma AB and Idogen AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance